Aripiprazole lai two-injection start in a 16 year-old with Schizophrenia

INTRODUCTION: Aripiprazole LAI is approved for the treatment of schizophrenia in adults. Recently, Europe and Canada approved the use of the two-injection start (TIS) regimen: two separate injections of 400 mg long-acting aripiprazole along with a single 20 mg dose of oral aripiprazole. Aripiprazole...

Descripción completa

Detalles Bibliográficos
Autores principales: Marpepa, B., Appignanesi, C., Orsolini, L., Volpe, U., Salvi, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568000/
http://dx.doi.org/10.1192/j.eurpsy.2022.2058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568000/
http://dx.doi.org/10.1192/j.eurpsy.2022.2058

Ejemplares similares